Innovative point-of-care molecular diagnostic test for COVID-19 in India -- MEDICA - World Forum for Medicine

13.11.2020

Molbio Diagnostics (P) Limited

Innovative point-of-care molecular diagnostic test for COVID-19 in India

A similar approach was used in India to augment testing for COVID-19 in underserved areas and health-care facilities. A combination of different tests and testing platforms has been used to augment capacity to 1·2 million tests per day, as of Sept 25, 2020.2 Indigenous portable Truelab (Molbio Diagnostics, India) workstations, previously used and recommended by WHO for tuberculosis3 and also deployed for detection of Nipah virus disease (unpublished) and leptospirosis (unpublished), are now being used for detection of SARS-CoV-2.

Exhibitor Data Sheet